Presumptive cardiac dyspnoea | Presumptive non-cardiac dyspnoea | P value | ||
N | 295 | 75 | ||
Age, mean (SD) | 77.0 (11.9) | 72.9 (10.9) | 0.007 | |
Female gender | 145 (49.2%) | 43 (57.3%) | 0.21 | |
Previous hosp for HF | 98 (33.2%) | 7 (9.3%) | <0.001 | |
Known valve disease | 36 (12.2%) | 2 (2.7%) | 0.015 | |
Known HFrEF | 56 (19.0%) | 0 (0.0%) | <0.001 | |
IHD | 76 (25.8%) | 12 (16.0%) | 0.076 | |
Diabetes | 61 (20.7%) | 16 (21.3%) | 0.90 | |
COPD | 91 (30.8%) | 51 (68.0%) | <0.001 | |
Atrial fibrillation, history or new | 150 (50.8%) | 27 (36.0%) | 0.022 | |
Hypertension, history or >140/90 mm Hg | 216 (73.2%) | 47 (62.7%) | 0.072 | |
Anaemia (HgB <8.1 M or <7.4 F) | 116 (39.3%) | 39 (52.0%) | 0.047 | |
Chronic kidney disease | ≥90 | 46 (15.7%) | 13 (17.3%) | 0.86 |
Groups from eGFR | 60–89 | 127 (43.3%) | 30 (40.0%) | |
30–59 | 120 (41.0%) | 32 (42.7%) | ||
NT-proBNP, median (IQR), ng/L | 3102 (1322, 8729) | 2712 (1686, 9034) | 0.74 | |
Charlson Comorbidity Index, mean (SD) | 2.5 (1.9) | 3.1 (2.3) | 0.023 | |
Signs and symptoms of HF on examination | ||||
Boston score | 0–4 point | 30 (10.2%) | 3 (4.0%) | 0.005 |
5–7 point | 83 (28.1%) | 35 (46.7%) | ||
8–12 point | 182 (61.7%) | 37 (49.3%) | ||
Framingham HF | Negative | 100 (33.9%) | 42 (56.0%) | <0.001 |
Positive | 195 (66.1%) | 33 (44.0%) |
COPD, chronic obstructive pulmonary disease;HF, heart failure; HFrEF, heart failure due to reduced EF; IHD, ischaemic heart disease; eGFR, estimated glomerular filtration rate.